SEC23B is Altered For Rare Blood Disorder  Type II Congenital dyserythropoietic anemia

SEC23B is Altered For Rare Blood Disorder Type II Congenital dyserythropoietic anemia

Cancer-News

1 year
95 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Charis Eng, MD, PhD, Genomic Medicine Institute - Cleveland Clinic, explains SEC23B is Altered For Rare Blood Disorder Type II Congenital dyserythropoietic anemia at AACR 2018.
Up Next Autoplay